A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Jeffrey Schultz, M.D., The Bronx

Ophthalmic Consultants of Long Island, Lynbrook

Rochester Ophthalmological Group, Rochester

Seidenberg Protzko Eye Associates, Havre de Grace

Alan L Robin, M.D., Baltimore

Virginia Eye Consultants, Norfolk

Charlotte Eye Ear Nose & Throat Associates, P.A., Belmont

Coastal Research Associates, LLC, Roswell

Clayton Eye Center, Morrow

Taustine Eye Center, Louisville

Great Lakes Eye Care, Saint Joseph

Bradley Kwapiszeski, MD, Shawnee Mission

The Eye Institute, Tulsa

Texan Eye, Austin

Medical Center Ophth. Associates, San Antonio

Stacy R. Smith, M.D., Salt Lake City

United Medical Research Institute, Inglewood

Kenneth Sall, M.D., Artesia

Centre For Health Care, Poway

Aesthetic Eye Care Institute, Newport Beach

Bacharach practice, Petaluma